Palynziq Injection, Solution
Product Images NDC 68135-673

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Palynziq (NDC 68135-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biomarin Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Palynziq 1)

This is a table showing the mean observed blood phenylalanine levels in micromol/L for a study (Study 302) that was randomized and tested a drug called Palynziq at different doses (20mg and 40mg) compared to a placebo. The table shows the different time points when these measurements were taken: pre-treatment baseline, withdrawal baseline, withdrawal week 4, and withdrawal week 8.*

FDA Label Image

Figure I (Palynziq 10)

FDA Label Image

Figure J (Palynziq 11)

FDA Label Image

Figure K (Palynziq 12)

FDA Label Image

Figure L (Palynziq 13)

FDA Label Image

Figure M (Palynziq 14)

FDA Label Image

Figure N (Palynziq 15)

FDA Label Image

Figure O (Palynziq 16)

Pinch Skin is a likely an instruction or a phrase that refers to the act of pinching the skin. The context and purpose of pinching the skin are not available.*

FDA Label Image

Figure P (Palynziq 17)

This appears to be a set of instructions for a medical procedure involving moving one's hand into a position ready for needle injection.*

FDA Label Image

Figure Q (Palynziq 18)

FDA Label Image

Figure R (Palynziq 19)

FDA Label Image

Figure A (Palynziq 2)

FDA Label Image

Figure S (Palynziq 20)

FDA Label Image

Figure T (Palynziq 21)

FDA Label Image

2.5 mg Carton (Palynziq 22)

This appears to be a product description for a medication called Pegvaliase-palz, which comes in a single-dose pre-filled syringe containing 2.5 mg/0.5mL, and is intended for subcutaneous use only. The medication should be stored in the refrigerator between 2°C to 8°C, and protected from light. If needed, the medication can be stored at room temperature between 20°C to 25°C for up to 30 days, but should not be placed back in the refrigerator after that time. The syringe also contains sodium chloride, trans-cinnamic acid, and tromethamis. There is further information related to prescribing information that is not available in the text.*

FDA Label Image

2.5 mg Tray Cover (Palynziq 23)

This is a description of Palemziq, an injection medication administered subcutaneously using a single-use pre-filled syringe. Each syringe contains 2.5 mg/0.5 mL of the medication and is for one-time use only. The medication comes in a carton that must be refrigerated at 36°F to 46°F (2°C to 8°C) to protect it from light and should not be frozen or shaken. There is no preservative in the medication, and the usual dosage can be found in the prescribing information. The NDC number is 68135.056-80 Rxonly.*

FDA Label Image

2.5 mg Syringe Label (Palynziq 24)

Palynziq is a medication with the drug name pegvaliase-papz. Additional information is not available.*

FDA Label Image

10 mg Carton (Palynziq 25)

This appears to be a description for a medication called "pegvaliasa-papz" that comes in a single-dose pre-filled syringe. The medication guide and instructions for use should be provided to each patient, and it is only intended for subcutaneous use. It should be stored in a refrigerator between 2°C and 8°C (36°F to 46°F) and should not be frozen or shaken. The usual dosage is 10mg delivered in 0.5 mL. The medication contains sodium chloride, trans-cinnamic acid, and tromethamine hydrochloride. There are no preservatives included.*

FDA Label Image

10 mg Tray Cover (Palynziq 26)

This text provides limited information regarding a medical product named NOG eB135.756.10 in the form of a prefilled syringe with a dosage of 10mg/0.5mL. It is intended for subcutaneous use only. There are instructions provided regarding the handling and storage of the product, including protecting it from light, not freezing or shaking it, and discarding it after use. However, there is little information regarding the active ingredients or the purpose of the medication.*

FDA Label Image

10 mg Syringe Label (Palynziq 27)

FDA Label Image

20 mg Carton (Palynziq 28)

This is the description of a medication product called Palyniq. It is a 20mg/mL solution for subcutaneous use only. The product is stored in the refrigerator at a temperature of 2°C to 8°C to protect it from light. It should not be frozen or shaken. Palyniq may be stored at room temperature between 20°C to 25°C for up to 30 days. The single-dose prefilled syringe contains 20mg pegallass-papzin 1mL and some inactive ingredients such as sodium chiorids, trans-cinnarmic acid, tromethamins and tromethamins hycroshiorde. The carton includes one tray with syringe, prescribing information, medication guide and instructions for use. The usual dosage is described in the prescribing information.*

FDA Label Image

20 mg Tray Cover (Palynziq 29)

Product Name: Palynzic. This is a prescription drug with NDC number 68135-673-30. It is used for subcutaneous administration only. The drug comes in a single-dose prefilled syringe and the concentration is 120 mgmL. The carton should be protected from light and should not be frozen or shaken to prevent damage. The drug must be discarded after use.*

FDA Label Image

Figure B (Palynziq 3)

This appears to be a list of components or features related to a medical syringe. It includes a "Viewing Plunger", a "Needle Cap Window", a "Plunger Head", a "Syringe Finger", and "Label Grips". It is not clear from this text what these components do or how they work together.*

FDA Label Image

20 mg Syringe Label (Palynziq 30)

Palynziq™ is a medication with the active ingredient pegvaliase-pqpz. Further information is not available from the provided text.*

FDA Label Image

20 mg Carton (multi Pack) (Palynziq 31)

FDA Label Image

Figure C (Palynziq 4)

This document appears to be a chart or table listing different strengths of medication in milligrams and their corresponding colors. The available information includes 2.5mg in white, 10mg in green, and 20mg in blue.*

FDA Label Image

Figure D (Palynziq 5)

FDA Label Image

Figure E (Palynziq 6)

FDA Label Image

Figure F (Palynziq 7)

FDA Label Image

Figure G (Palynziq 8)

FDA Label Image

Figure H (Palynziq 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.